Circulating fatty acid binding protein 4 ( FABP ‐4) concentrations and mortality in individuals with colorectal cancer in the European Prospective Investigation into Cancer and Nutrition study
International Journal of Cancer · 2026
DOI: 10.1002/ijc.70090 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, 2026. Verfasst von Thu Thi Pham und 25 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Epidemiology Research Group, Max-Delbrueck-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany. Hauptthemen laut MEDLINE: Fatty Acid-Binding Proteins, Colorectal Neoplasms, Biomarkers, Tumor. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Research Fund (FIS)-Instituto de Salud Carlos III (ISCIII), Associazione Italiana per la Ricerca sul Cancro-AIRC-Italy, Netherlands Cancer Registry (NKR).
Abstract (Originalsprache)
Human fatty acid binding protein‐4 (FABP‐4), a protein elevated in obesity that promotes colon cancer cell invasiveness and metastasis, may be associated with higher mortality in individuals with colorectal cancer (CRC) and may serve as a mediator of the obesity–mortality association in these individuals. We used a causal diagram to inform covariate selection and applied Cox proportional hazards models to estimate hazard ratios (HRs) for CRC‐specific, non‐CRC‐specific, and all‐cause mortality by FABP‐4 levels measured in baseline blood samples from 1371 incident CRC cases from the European Prospective Investigation into Cancer and Nutrition cohort. Competing risk analyses were adapted for CRC and non‐CRC deaths. Mediation analyses were conducted to estimate total effects (TEs), direct effects (DEs), and mediation proportions (MPs) by FABP‐4 of pre‐diagnostic body mass index (BMI) on mortality. In the fully adjusted model including BMI, higher circulating FABP‐4 concentrations were associated with higher CRC mortality (HR Q4vsQ1 = 1.49; 95% CI: 1.11–2.00) and all‐cause mortality (HR Q4vsQ1 = 1.49; 95% CI: 1.15–1.93), but not statistically associated with non‐CRC mortality (HR Q4vsQ1 = 1.51; 95% CI: 0.82–2.76). The TE and DE per 5 kg/m 2 of BMI on all‐cause mortality were 1.21; 95% CI: 1.10–1.34, and 1.13; 95% CI: 1.02–1.26, respectively, with a MP of 34.5% ( p = .002) by FABP‐4. For CRC‐specific and non‐CRC‐specific mortality, MPs by FABP‐4 were 33.7% ( p = .03) and 36.1% ( p = .02), respectively. In conclusion, higher concentrations of FABP‐4 were associated with higher CRC‐specific and all‐cause mortality in individuals with CRC. FABP‐4 was a significant partial mediator of the adiposity‐mortality relationship in individuals with CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Epidemiology Research Group, Max-Delbrueck-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.
- Department of Epidemiological Methods and Etiological Research, Leibniz Institute for Prevention Research and Epidemiology-BIPS, Bremen, Germany.
- Faculty of Human and Health Sciences, University of Bremen, Bremen, Germany.
- Nutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), World Health Organization, Lyon, France.
- Department of Epidemiology, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
- Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.
ORCID-Profile: Thu Thi Pham, Katharina Nimptsch, Krasimira Aleksandrova, Mazda Jenab, Veronika Fedirko, Gianluca Severi, Renée Turzanski Fortner, Carlotta Sacerdote, Alicia Heath, Dagfinn Aune
Förderung
- Health Research Fund (FIS)-Instituto de Salud Carlos III (ISCIII)
- Associazione Italiana per la Ricerca sul Cancro-AIRC-Italy
- Netherlands Cancer Registry (NKR)
- Compagnia di SanPaolo and National Research Council
- Dutch Ministry of Public Health, Welfare and Sports (VWS)
- German Cancer Aid
- Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London
- German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE)
Zitieren
APA
Pham, T. T., Nimptsch, K., Aleksandrova, K., Jenab, M., Fedirko, V., Olsen, A., Tjønneland, A., Cadeau, C., Severi, G., Schulze, M. B., Fortner, R. T., Katzke, V., Agnoli, C., Sacerdote, C., Tumino, R., Signoriello, S., Trobajo-Sanmartín, C., Gómez, J. H., Chirlaque, M. D., …, & Pischon, T. (2026). Circulating fatty acid binding protein 4 ( FABP ‐4) concentrations and mortality in individuals with colorectal cancer in the European Prospective Investigation into Cancer and Nutrition study. International Journal of Cancer. https://doi.org/10.1002/ijc.70090
Vancouver
Pham TT, Nimptsch K, Aleksandrova K, Jenab M, Fedirko V, Olsen A, et al. Circulating fatty acid binding protein 4 ( FABP ‐4) concentrations and mortality in individuals with colorectal cancer in the European Prospective Investigation into Cancer and Nutrition study. International Journal of Cancer. 2026. doi:10.1002/ijc.70090
BibTeX
@article{Pham2026,
author = {Pham, Thu Thi and Nimptsch, Katharina and Aleksandrova, Krasimira and Jenab, Mazda and Fedirko, Veronika and Olsen, Anja and Tjønneland, Anne and Cadeau, Claire and Severi, Gianluca and Schulze, Matthias B and Fortner, Renée Turzanski and Katzke, Verena and Agnoli, Claudia and Sacerdote, Carlotta and Tumino, Rosario and Signoriello, Simona and Trobajo-Sanmartín, Camino and Gómez, Jesús-Humberto and Chirlaque, María-Dolores and Sánchez, Maria-Jose and Crous-Bou, Marta and May, Anne and Heath, Alicia and Aune, Dagfinn and Weiderpass, Elisabete and Pischon, Tobias},
title = {Circulating fatty acid binding protein 4 ( FABP ‐4) concentrations and mortality in individuals with colorectal cancer in the European Prospective Investigation into Cancer and Nutrition study},
journal = {International Journal of Cancer},
year = {2026},
doi = {10.1002/ijc.70090}
}
EUVIMED